Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

First Hawaiian Q2 EPS $0.46 Beats $0.45 Estimate

First Hawaiian (NASDAQ:FHB) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.45 by 2.22 percent. This is a 32.35 percent decrease over earnings of $0.68 per share from the
byBill Haddad
July 29, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

First Hawaiian (NASDAQ:FHB) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.45 by 2.22 percent. This is a 32.35 percent decrease over earnings of $0.68 per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Eledon Pharmaceuticals Received FDA Clearance of IND Application to Evaluate Tegoprubart for the Prevention of Rejection in Kidney Transplant Recipients

By Charles Gross
August 1, 5:14 AM
Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of innovative and impactful treatments for organ and cell transplantation, autoimmune conditions, and neurodegenerative disease, today announced that the U.S.

ELDN